Daxor logo

DaxorNASDAQ: DXR

Profile

Sector:

Healthcare

Country:

United States

IPO:

25 July 1983

Next earnings report:

25 March 2025

Last dividends:

05 January 2018

Next dividends:

N/A
$43.08 M
-25%vs. 3y high
33%vs. sector
-vs. 3y high
-vs. sector
-58%vs. 3y high
46%vs. sector
-vs. 3y high
-vs. sector

Price

regular market | Fri, 25 Oct 2024 13:30:00 GMT
$8.90-$0.10(-1.11%)

Dividend

No data over the past 3 years
No data over the past 3 years
No data over the past 3 years
No data over the past 3 years

Analysts recommendations

Institutional Ownership

DXR Latest News

Daxor Corporation to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit
globenewswire.com08 October 2024 Sentiment: POSITIVE

Oak Ridge, TN, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit with Maxim Director of Research and Senior Healthcare Analyst Anthony Vendetti. The summit is being held from October 15 – 17, 2024.

Daxor Corporation Streamlines Regulatory Strategy for Groundbreaking Diagnostic Device
globenewswire.com27 September 2024 Sentiment: POSITIVE

Company to Focus on 510(k) Approval Path, Accelerating Time-to-Market Oak Ridge, TN, Sept. 27, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces a strategic update to its regulatory approach for its novel diagnostic blood volume analyzer platform.

Daxor Corporation to Exhibit at the Heart Failure Society of America Annual Scientific Meeting 2024
globenewswire.com19 September 2024 Sentiment: POSITIVE

Oak Ridge, TN, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (NASDAQ: DXR), the global leader in blood volume measurement technology, today announces its participation in the Annual Scientific Meeting of the Heart Failure Society of America (HFSA), taking place September 27-30 at the Georgia World Congress Center and Signia by Hilton Atlanta. The event will gather the world's top heart failure experts.

Leading Central Florida Hospital Implements Daxor's BVA-100™ Blood Volume Diagnostic for Heart Failure Patient Care
globenewswire.com04 September 2024 Sentiment: POSITIVE

1,000 Bed Comprehensive Medical Center Launches ezBVA Lab Program Oak Ridge, TN, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of its blood volume analysis (BVA) capabilities through its ezBVA Lab service.

Daxor Corporation to Present at the H.C. Wainwright 26th Annual Global Investment Conference
globenewswire.com03 September 2024 Sentiment: POSITIVE

Oak Ridge, TN, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 26th Annual Global Investment Conference being held on September 9-11, 2024 in New York City at the Lotte New York Palace Hotel.

Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
globenewswire.com29 August 2024 Sentiment: POSITIVE

Community Hospital Purchases BVA Analyzer With Focus on Improving Outpatient Heart Failure Care Oak Ridge, TN, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces the expansion of its blood volume analysis (BVA) technology through the acquisition of the BVA analyzer. This advancement not only enhances revenue streams, but also sets the stage for projected accelerated sales growth for the rest of the year.

Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
globenewswire.com05 August 2024 Sentiment: POSITIVE

Daxor's ezBVA Lab Service Spearheads Growth and Broader Market Adoption Oak Ridge, TN, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, today announces the expansion of blood volume analysis (BVA) in three new facilities. Daxor's ezBVA lab service is a state-of-the-art CLIA certified facility that provides on-demand, next day blood volume analysis results.

Daxor Corporation to Showcase the Benefits of BVA-100™ Guided-Care at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting
globenewswire.com18 June 2024 Sentiment: POSITIVE

Oak Ridge, TN, June 18, 2024 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today it will exhibit at the American Association of Heart Failure Nurses (AAHFN) 20th Annual Meeting from June 20-22nd, 2024 at the Rosen Shingle Creek Resort in Orlando, Florida. The AAHFN is a specialty organization dedicated to advancing nursing education, clinical practice, and research to improve heart failure patient outcomes.

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript
Seeking Alpha25 March 2024 Sentiment: NEUTRAL

Daxor Corporation (DXR) Q4 2023 Earnings Call Transcript

Daxor Corporation to Present at the H.C. Wainwright 25th Annual Global Investment Conference
GlobeNewsWire07 September 2023 Sentiment: POSITIVE

Oak Ridge, TN, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), the global leader in blood volume measurement technology, announces today that CEO and President Michael Feldschuh will present at the H.C. Wainwright 25th Annual Global Investment Conference being held on September 11 - 13, 2023 at the Lotte New York Palace.

What type of business is Daxor?

Daxor Corporation, a medical device company, provides blood volume measurement technology focused on blood volume testing. The company develops and markets BVA-100 Blood Volume Analyzer, a diagnostic blood test to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for used in a broad range of medical and surgical conditions. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was incorporated in 1971 and is headquartered in Oak Ridge, Tennessee. Daxor Corporation is a subsidiary of Estate Of Joseph Feldschuh.

What sector is Daxor in?

Daxor is in the Healthcare sector

What industry is Daxor in?

Daxor is in the Medical Instruments & Supplies industry

What country is Daxor from?

Daxor is headquartered in United States

When did Daxor go public?

Daxor initial public offering (IPO) was on 25 July 1983

What is Daxor website?

https://www.daxor.com

Is Daxor in the S&P 500?

No, Daxor is not included in the S&P 500 index

Is Daxor in the NASDAQ 100?

No, Daxor is not included in the NASDAQ 100 index

Is Daxor in the Dow Jones?

No, Daxor is not included in the Dow Jones index

When was Daxor the previous earnings report?

No data

When does Daxor earnings report?

The next expected earnings date for Daxor is 25 March 2025